Impact of central antagonist of cholecystokinin-1 receptors GB-115 on cognitive functions in patients with Generalized Anxiety Disorder

INTRODUCTION: Generalized anxiety disorder (GAD) is associated with reduced attention, inhibition, decrease of processing speed. The impact of a new peptide antagonist of central cholecystokinin-1 receptors (GB-115) on cognitive processes in patients with GAD is reported. OBJECTIVES: To research the...

Descripción completa

Detalles Bibliográficos
Autores principales: Dorofeeva, O., Metlina, M., Chepeliuk, A., Vinogradova, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563656/
http://dx.doi.org/10.1192/j.eurpsy.2022.490

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563656/
http://dx.doi.org/10.1192/j.eurpsy.2022.490

Ejemplares similares